<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of an Exclusive License: The Development of an Anti-GPC3 Chimeric Antigen Receptor (CAR) Based on YP7 for the Treatment of Human Cancers</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of an Exclusive License: The Development of an Anti-GPC3 Chimeric Antigen Receptor (CAR) Based on YP7 for the Treatment of Human Cancers</h1>
    <p class="timestamp">Published: 2016-05-18 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the inventions embodied in: Intellectual Property U.S. Provisional Patent Application 61/654,232 entitled "High- affinity Monoclonal Antibodies To Glypican-3 And Use Thereof" [HHS Ref. E-136-2012/0-US-01]; PCT Patent Application PCT/US2013/043633 entitled "High-affinity M...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2016-11660</p>
    <p><strong>Publication Date:</strong> 2016-05-18</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2016/05/18/2016-11660/prospective-grant-of-an-exclusive-license-the-development-of-an-anti-gpc3-chimeric-antigen-receptor">https://www.federalregister.gov/documents/2016/05/18/2016-11660/prospective-grant-of-an-exclusive-license-the-development-of-an-anti-gpc3-chimeric-antigen-receptor</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2016-11660</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
